FDA Approves First Drug to Delay Onset of Type 1 Diabetes
Tzield targets the autoimmune issues that drive the disease, rather than its symptoms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Tzield targets the autoimmune issues that drive the disease, rather than its symptoms
Only registered members have full access to PracticeUpdate content.